Using an app to help control high blood pressure in African-Americans
FAITH! Hypertension App to Improve Hypertension Control and Cardiovascular Health Among African-Americans: A Decentralized Randomized Clinical Trial
This study is testing an app that helps African-American adults with high blood pressure manage their condition better than those who only get regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT06346886 on ClinicalTrials.gov |
What this trial studies
This study tests an app-based intervention designed to improve hypertension management and self-care among African-American adults with uncontrolled hypertension. Participants will use the FAITH! HTN app and their progress will be compared to those receiving standard care. The effectiveness of the app will be evaluated at baseline, immediately after the intervention, and at 3 and 6 months post-intervention. The goal is to determine if the app leads to better blood pressure control and overall cardiovascular health.
Who should consider this trial
Good fit: Ideal candidates are African-American adults aged 18 and older with uncontrolled hypertension who are patients at Neighborhood HealthSource in Minneapolis.
Not a fit: Patients who do not have access to a smartphone or the internet, or who do not meet the criteria for uncontrolled hypertension, may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve blood pressure control and health outcomes for African-American patients with hypertension.
How similar studies have performed: Other studies have shown promise with app-based interventions for hypertension management, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * African-American (AA) adults that are established patients at Neighborhood HealthSource in Minneapolis, Minnesota. * Receives primary care (i.e., has designated primary care provider) at the partnering FQHCs and intent to continue care there for next 12 months * African American race/ethnicity * Men and women aged ≥18 years * Uncontrolled HTN (defined as Stage 2 HTN with a BP ≥140/90 mmHg \[as per 2017 American College of Cardiology/American Heart Association HTN Guidelines32\] at most recent outpatient evaluation, with or without BP medications) * Documented diagnosis of HTN in EHR * At least 1 office visit at the partnering FQHCs in the prior year * Smartphone ownership (supporting iOS or Android Systems) * Active email address and willingness to utilize it throughout the study * Basic Internet navigation skills (for example, can search for information on websites, open and send emails) * Access to the Internet on at least a weekly basis (such as at home, a family member's or friend's home, church, library/community center, school/university, Internet café, etc.)? Exclusion Criteria: * Diagnosis of a serious medical condition or disability that would make participation difficult (i.e. visual or hearing impairment, mental disability that would preclude independent use of the app). * No primary care provider at partnering FQHC
Where this trial is running
Rochester, Minnesota
- Mayo Clinic — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: LaPrincess Brewer, M.D., M.P.H — Mayo Clinic
- Study coordinator: Lainey Moen
- Email: Moen.Lainey@mayo.edu
- Phone: 507-266-7062
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.